Anavex Life Sciences Corp (AVXL)

[sokol]

So far, I find today's Biogen announcement sketchy, and I am curious about any adverse effects of the patients receiving the highest dosage that I understand was administered intravenously over 18 months. Reportedly, it was these patients receiving the highest dosage that benefited. Additionally, what complications occurred with the intravenous injections besides the fact that a drug administered intravenously is not as advantageous, convenient, and cost effective as taking your pills in your natural living environment at home, work or play.

Analysts are urging caution. So, Bio, I think you are correct!

"'Jefferies analyst Michael Yee remains cautious of Biogen and wrote investors have been "pretty bearish on Alzheimer's" treatments because the disease is so difficult to treat. Yee maintained his "hold" recommendation on the stock, arguing that the latest data was not significant enough to change his rating. The stock currently has 14 "buy" and six "hold" ratings on it from analysts."

Biogen Shares Soar on Positive Alzheimer's Drug Results
https://www.thestreet.com/investing/stocks/alzheimer-drug-results-boost-biogen-shares-14643336?puc=yahoo&cm_ven=YAHOO&yptr=yahoo